Gwinnutt C L, Walker R W, Meakin G
Department of Anaesthesia, Hope Hospital, Salford.
Br J Anaesth. 1991 Jul;67(1):13-6. doi: 10.1093/bja/67.1.13.
Antagonism of intense neuromuscular block induced by atracurium 0.5 mg kg-1 was attempted in four groups of six children using one of two doses of neostigmine (0.05 mg kg-1 and 0.1 mg kg-1) or of edrophonium (0.5 mg kg-1 and 1.0 mg kg-1) when the first twitch of the post-tetanic count (PTC1) was 10% of control. For comparison with normal practice, a fifth group received neostigmine 0.05 mg kg-1 when the first twitch of the train-of-four was 10% of control. Total recovery time from PTC1 10% to a train-of-four ratio of 0.8 was not reduced by early administration of the anticholinesterases, compared with conventional administration of neostigmine at T1 10%. However, recovery from intense block was faster after neostigmine than edrophonium (P less than 0.01). Doubling the doses of the anticholinesterases did not reduce the recovery time and had the effect of increasing variability. We conclude that there is no clinical advantage in attempting to antagonize intense neuromuscular block in children using normal or increased doses of neostigmine or edrophonium.
当强直刺激后计数(PTC)的第一个肌颤搐(PTC1)为对照值的10%时,在四组每组6名儿童中尝试使用两种剂量的新斯的明(0.05 mg/kg和0.1 mg/kg)或依酚氯铵(0.5 mg/kg和1.0 mg/kg)之一拮抗0.5 mg/kg阿曲库铵所致的深度神经肌肉阻滞。为了与常规做法进行比较,第五组在四个成串刺激的第一个肌颤搐为对照值的10%时给予0.05 mg/kg新斯的明。与在T1 10%时常规给予新斯的明相比,早期给予抗胆碱酯酶药物并未缩短从PTC1 10%恢复到四个成串刺激比值为0.8的总恢复时间。然而,新斯的明后深度阻滞的恢复比依酚氯铵更快(P<0.01)。抗胆碱酯酶药物剂量加倍并未缩短恢复时间,反而增加了变异性。我们得出结论,使用正常剂量或增加剂量的新斯的明或依酚氯铵拮抗儿童深度神经肌肉阻滞没有临床优势。